Biofrontera Inc. (BFRI) vs Tvardi Therapeutics, Inc. (TVRD)
A side-by-side comparison of Biofrontera Inc. and Tvardi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BFRI
Biofrontera Inc.
$0.93HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TVRD
Tvardi Therapeutics, Inc.
$1.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BFRI vs TVRD
growth of $100 · dividends reinvested · last 1yBFRI +32.8% (+32.8%/yr)TVRD -76.7% (-76.7%/yr)BFRI compounded faster over this window
Log scale — wide-divergence pair
BFRI TVRD
BFRI vs TVRD: by the numbers
- •BFRI is the larger company ($12M vs $10M market cap).
- •Both run net losses; TVRD's is the smaller (0.00% vs -13.78% net margin).
Metrics side by side
Valuation
| Metric | BFRI | TVRD |
|---|---|---|
| P/S ratio | 0.26 | N/A |
| P/B ratio | 2.00 | 1.21 |
Profitability
| Metric | BFRI | TVRD |
|---|---|---|
| Gross margin | 84.45% | 0.00% |
| Operating margin | -21.94% | 0.00% |
| Net margin | -13.78% | 0.00% |
| ROE | -106.87% | -310.94% |
| ROIC | -32.27% | -323.71% |
Growth (annualized)
| Metric | BFRI | TVRD |
|---|---|---|
| Revenue CAGR (5Y) | 15.55% | N/A |
Go deeper
Dig into the metrics
Biofrontera ROETvardi Therapeutics ROEBiofrontera operating marginTvardi Therapeutics operating marginBiofrontera revenue growthTvardi Therapeutics revenue growthBiofrontera free cash flowTvardi Therapeutics free cash flow
Biofrontera & Tvardi Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.